Archive for May, 2009
Sunday, May 31st, 2009
Allos Therapeutics Reports Updated Data from Pivotol Phase 2 … – WELT ONLINE
Allos Therapeutics Reports Updated Data from Pivotol Phase 2 …WELT ONLINE, GermanyAllos Therapeutics, Inc. (Nasdaq: ALTH) today reported updated data from the Company's pivotal Phase 2 PROPEL study of pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). The overall response rate [...]
Posted in Uncategorized | No Comments »
Friday, May 29th, 2009
Lymphoma Foundation of America – Lymphomahelp.orgLymphoma Foundation of America is the national organization devoted solely to helping lymphoma patients and their families.
Lymphoma – Symptoms, Treatment and PreventionSymptoms, Treatment and Prevention of Lymphoma Definition of Lymphoma; Description of Lymphoma; Causes and Risk Factors of Lymphoma
Non-Hodgkin Lymphoma Home Page – National Cancer InstituteInformation about non-Hodgkin [...]
Posted in Uncategorized | No Comments »
Friday, May 29th, 2009
FDA Will Consider Arzerra For Some Leukemia Patients > GSKWall Street JournalBy Jennifer Corbett Dooren WASHINGTON (Dow Jones)–The Food and Drug Administration said Wednesday that it will consider approving Arzerra, a proposed leukemia treatment that would be marketed by GlaxoSmithKline PLC (GSK) for patients who have failed …Glaxo, Genmab's Arzerra Draws FDA Staff Questions BloombergUS [...]
Posted in Uncategorized | No Comments »
Thursday, May 28th, 2009
Leukemia – Diagnosis and Treatment Options at Mayo ClinicLeukemia diagnosis and comprehensive treatment options for chronic and acute leukemia.
The Leukemia & Lymphoma SocietyFighting leukemia, lymphoma, Hodgkin’s disease and myeloma. The Therapy Acceleration Program April Update The latest news on our research efforts for new blood cancer therapies
Leukemia Lawyers and Benzene – Attorney Information [...]
Posted in Uncategorized | No Comments »
Thursday, May 28th, 2009
Overview of lymphomas, including Hodgkin’s and non-Hodgkin’s Types of Lymphoma There are two primary types of lymphoma: Hodgkin lymphoma (HL, also called Hodgkin’s disease Read More
Fighting leukemia, lymphoma, Hodgkin’s disease and myeloma. The Therapy Acceleration Program April Update The latest news on our research efforts for new [...]
Posted in Uncategorized | No Comments »
Thursday, May 28th, 2009
For mixed-race patients with leukemia, finding a bone marrow donor can – Minneapolis Star TribuneHAYWARD, Calif. – If Nick Glasgow were white, he would have a nearly 90 percent chance of finding a matching bone marrow donor who could cure his leukemia. But because the 28-year-old bodybuilder is one-quarter Japanese, his doctor [...]
Posted in Uncategorized | No Comments »
Tuesday, May 26th, 2009
Researchers find similarities in lymphoma among humans, canines – WRAL.com
Researchers find similarities in lymphoma among humans, caninesWRAL.com, NCAt least that is what researchers are trying to determine as they work to improve lymphoma treatment for people. Truman is a 6-year-old bloodhound. Last summer, owners Sharman and Clayton Veger noticed swelling in the lymph nodes on his [...]
Posted in Uncategorized | No Comments »
Monday, May 25th, 2009
When a good coach gets some bad news – San Francisco Chronicle
When a good coach gets some bad newsSan Francisco Chronicle, USAWever plucked the bracelet off and kept his mind on the kids and baseball, setting aside the words "anaplastic large-cell lymphoma" for now. He has not made a secret of the cancer, which was [...]
Posted in Uncategorized | No Comments »
Sunday, May 24th, 2009
Learn about lymphoma. Read the latest research on lymphoma symptoms, diagnosis, current lymphoma treatments. Find information on different lymphoma types including non-Hodgkin’s Read More
Find information on lymphoma including Hodgkin’s disease, non-Hodgkin’s lymphoma, and others. Covers symptoms, tests, treatments, medications, and more. Read More
Posted in Uncategorized | No Comments »
Sunday, May 24th, 2009
ORLANDO, Fla., May 18 Mayo-lymphoma-study ORLANDO, Fla. , May 18 /PRNewswire-USNewswire/ — When combined with a cocktail of chemotherapy drugs, two monoclonal antibodies, instead of one, appear to offer superior results in patients with diffuse Read More
Posted in Uncategorized | No Comments »